Global Infectious Disease Diagnostics Market Growth (Status and Outlook) 2026-2032

Product Code: 2014651

Industry: Pharma & Healthcare

Published: Jun 10,2026

Pages: 138

Delivery Time: 2-3 business days

Global Infectious Disease Diagnostics Market Growth (Status and Outlook) 2026-2032

Product Code: 2014651

Industry: Pharma & Healthcare

Published: Jun 10,2026

Pages: 138

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Infectious Disease Diagnostics market size is predicted to grow from US$ 25377 million in 2025 to US$ 34910 million in 2032; it is expected to grow at a CAGR of 4.8% from 2026 to 2032.

Infectious Disease Diagnostics refers to a system of in-vitro diagnostic reagents, instruments, automated platforms, informatics systems, and quality-control solutions used to detect, identify, type, quantify, and clinically interpret pathogens or infection-related markers in human samples such as blood, respiratory specimens, urine, stool, cerebrospinal fluid, secretions, and tissue. It targets infectious diseases caused by viruses, bacteria, fungi, parasites, mycoplasma, chlamydia, and other pathogens, and may detect nucleic acids, antigens, antibodies, toxins, resistance genes, or host immune-response markers. The field covers molecular diagnostics, immunodiagnostics, microbiological culture, mass spectrometry identification, antimicrobial susceptibility testing, point-of-care testing, multiplex panels, and sequencing. It is widely used in clinical diagnosis, infection control, antimicrobial stewardship, public health surveillance, border quarantine, and epidemic early warning, supporting early detection, diagnosis, isolation, treatment, and precise prevention.The average gross   profit margin of this product is 53%.

Infectious disease diagnostics is evolving from single-outbreak emergency demand into a long-term sector jointly driven by clinical care, public health security, and healthcare-system resilience. Emerging infectious diseases, seasonal respiratory outbreaks, chronic viral infection management, tuberculosis and antimicrobial resistance control, hospital-acquired infection monitoring, and rational antimicrobial use are all driving continuous investment in rapid, precise, and traceable testing capabilities across healthcare institutions and public health systems. Government documents continue to strengthen disease control systems, medical-public health coordination, and interconnection of pathogen testing data, while corporate annual reports show that global diagnostic leaders regard infectious disease testing as an important strategic direction across molecular diagnostics, immunodiagnostics, and microbiology. Multi-platform integration, multiplex pathogen testing, automated workflows, and data-driven surveillance will continue to expand the value boundary of the industry.The infectious disease diagnostics industry faces multiple challenges, including demand volatility, pricing pressure, regulatory access, technology iteration, healthcare cost control, and product homogenization. After the pandemic, demand for certain single-pathogen tests has normalized, requiring companies to shift from short-cycle outbreak-driven products toward multi-scenario portfolios covering respiratory, blood-borne, gastrointestinal, reproductive tract, hospital-acquired infection, and antimicrobial resistance monitoring. Molecular diagnostics require high sensitivity, specificity, contamination control, and laboratory workflow capability. Immunodiagnostics emphasize antigen and antibody quality as well as lot-to-lot consistency, while microbiological diagnostics depend on sample processing, culture identification, antimicrobial susceptibility interpretation, and database accumulation. Future competition will not be limited to product pricing, but will depend on clinical evidence, test menus, platform compatibility, channel services, quality systems, and supply-chain resilience.Downstream demand is shifting from “whether testing is available” to “rapid differentiation, precise typing, medication guidance, and data reporting.” Large hospitals increasingly emphasize coordination among emergency departments, infectious disease departments, respiratory departments, intensive care units, clinical laboratories, and infection-control teams, using rapid etiological testing and resistance monitoring to shorten diagnostic time, optimize anti-infective therapy, and reduce nosocomial transmission risk. Primary healthcare institutions need tests that are easy to operate, short in turnaround time, and suitable for initial screening and triage. Independent clinical laboratories focus on batch testing, automated workflows, and cost efficiency, while public health systems emphasize pathogen-spectrum monitoring, regional epidemic trend assessment, and early warning. As medical-public health collaboration and infectious disease surveillance systems improve, infectious disease diagnostics will become a key infrastructure linking clinical treatment efficiency, hospital operational quality, and public health governance.

LPI (LP Information)' newest research report, the “Infectious Disease Diagnostics Industry Forecast” looks at past sales and reviews total world Infectious Disease Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Infectious Disease Diagnostics sales for 2026 through 2032. With Infectious Disease Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Infectious Disease Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Infectious Disease Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Blood Sample
    Respiratory Sample
    Urine Sample
    Other

Segmentation by Technology:
    Molecular Diagnostics
    Immunodiagnostics
    Culture & AST
    POCT Rapid Tests
    Other

Segmentation by Test Item:
    Respiratory Infections
    Hepatitis & Blood-borne
    Sexually Transmitted Infections
    Gastrointestinal Infections
    Other

Segmentation by Application:
    Public Hospitals
    Third-party Independent Laboratory
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    BD
    Danaher
    Abbott
    bioMérieux
    Hologic
    Thermo Fisher Scientific
    Roche
    DiaSorin
    QuidelOrtho
    Siemens Healthineers
    Qiagen
    Bio-Rad
    Wondfo Biotech
    Autobio
    Daan Gene
    Innovita
    Hybribio
    BioPerfectus
    Sansure
    Liferiver

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Infectious Disease Diagnostics Market Size (2021-2032)
        2.1.2 Infectious Disease Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032)
        2.1.3 World Current & Future Analysis for Infectious Disease Diagnostics by Country/Region (2021, 2025 & 2032)
    2.2 Infectious Disease Diagnostics Segment by Type
        2.2.1 Blood Sample
        2.2.2 Respiratory Sample
        2.2.3 Urine Sample
        2.2.4 Other
        2.2.5 Infectious Disease Diagnostics Market Size by Type
            2.2.5.1 Infectious Disease Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032)
            2.2.5.2 Global Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
    2.3 Infectious Disease Diagnostics Segment by Technology
        2.3.1 Molecular Diagnostics
        2.3.2 Immunodiagnostics
        2.3.3 Culture & AST
        2.3.4 POCT Rapid Tests
        2.3.5 Other
        2.3.6 Infectious Disease Diagnostics Market Size by Technology
            2.3.6.1 Infectious Disease Diagnostics Market Size CAGR by Technology (2021 VS 2025 VS 2032)
            2.3.6.2 Global Infectious Disease Diagnostics Market Size Market Share by Technology (2021-2026)
    2.4 Infectious Disease Diagnostics Segment by Test Item
        2.4.1 Respiratory Infections
        2.4.2 Hepatitis & Blood-borne
        2.4.3 Sexually Transmitted Infections
        2.4.4 Gastrointestinal Infections
        2.4.5 Other
        2.4.6 Infectious Disease Diagnostics Market Size by Test Item
            2.4.6.1 Infectious Disease Diagnostics Market Size CAGR by Test Item (2021 VS 2025 VS 2032)
            2.4.6.2 Global Infectious Disease Diagnostics Market Size Market Share by Test Item (2021-2026)
    2.5 Infectious Disease Diagnostics Segment by Application
        2.5.1 Public Hospitals
        2.5.2 Third-party Independent Laboratory
        2.5.3 Other
        2.5.4 Infectious Disease Diagnostics Market Size by Application
            2.5.4.1 Infectious Disease Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032)
            2.5.4.2 Global Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)

3 Infectious Disease Diagnostics Market Size by Player
    3.1 Infectious Disease Diagnostics Market Size Market Share by Player
        3.1.1 Global Infectious Disease Diagnostics Revenue by Player (2021-2026)
        3.1.2 Global Infectious Disease Diagnostics Revenue Market Share by Player (2021-2026)
    3.2 Global Infectious Disease Diagnostics Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion

4 Infectious Disease Diagnostics by Region
    4.1 Infectious Disease Diagnostics Market Size by Region (2021-2026)
    4.2 Global Infectious Disease Diagnostics Annual Revenue by Country/Region (2021-2026)
    4.3 Americas Infectious Disease Diagnostics Market Size Growth (2021-2026)
    4.4 APAC Infectious Disease Diagnostics Market Size Growth (2021-2026)
    4.5 Europe Infectious Disease Diagnostics Market Size Growth (2021-2026)
    4.6 Middle East & Africa Infectious Disease Diagnostics Market Size Growth (2021-2026)

5 Americas
    5.1 Americas Infectious Disease Diagnostics Market Size by Country (2021-2026)
    5.2 Americas Infectious Disease Diagnostics Market Size by Type (2021-2026)
    5.3 Americas Infectious Disease Diagnostics Market Size by Application (2021-2026)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Infectious Disease Diagnostics Market Size by Region (2021-2026)
    6.2 APAC Infectious Disease Diagnostics Market Size by Type (2021-2026)
    6.3 APAC Infectious Disease Diagnostics Market Size by Application (2021-2026)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia

7 Europe
    7.1 Europe Infectious Disease Diagnostics Market Size by Country (2021-2026)
    7.2 Europe Infectious Disease Diagnostics Market Size by Type (2021-2026)
    7.3 Europe Infectious Disease Diagnostics Market Size by Application (2021-2026)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Infectious Disease Diagnostics by Region (2021-2026)
    8.2 Middle East & Africa Infectious Disease Diagnostics Market Size by Type (2021-2026)
    8.3 Middle East & Africa Infectious Disease Diagnostics Market Size by Application (2021-2026)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Global Infectious Disease Diagnostics Market Forecast
    10.1 Global Infectious Disease Diagnostics Forecast by Region (2027-2032)
        10.1.1 Global Infectious Disease Diagnostics Forecast by Region (2027-2032)
        10.1.2 Americas Infectious Disease Diagnostics Forecast
        10.1.3 APAC Infectious Disease Diagnostics Forecast
        10.1.4 Europe Infectious Disease Diagnostics Forecast
        10.1.5 Middle East & Africa Infectious Disease Diagnostics Forecast
    10.2 Americas Infectious Disease Diagnostics Forecast by Country (2027-2032)
        10.2.1 United States Market Infectious Disease Diagnostics Forecast
        10.2.2 Canada Market Infectious Disease Diagnostics Forecast
        10.2.3 Mexico Market Infectious Disease Diagnostics Forecast
        10.2.4 Brazil Market Infectious Disease Diagnostics Forecast
    10.3 APAC Infectious Disease Diagnostics Forecast by Region (2027-2032)
        10.3.1 China Infectious Disease Diagnostics Market Forecast
        10.3.2 Japan Market Infectious Disease Diagnostics Forecast
        10.3.3 Korea Market Infectious Disease Diagnostics Forecast
        10.3.4 Southeast Asia Market Infectious Disease Diagnostics Forecast
        10.3.5 India Market Infectious Disease Diagnostics Forecast
        10.3.6 Australia Market Infectious Disease Diagnostics Forecast
    10.4 Europe Infectious Disease Diagnostics Forecast by Country (2027-2032)
        10.4.1 Germany Market Infectious Disease Diagnostics Forecast
        10.4.2 France Market Infectious Disease Diagnostics Forecast
        10.4.3 UK Market Infectious Disease Diagnostics Forecast
        10.4.4 Italy Market Infectious Disease Diagnostics Forecast
        10.4.5 Russia Market Infectious Disease Diagnostics Forecast
    10.5 Middle East & Africa Infectious Disease Diagnostics Forecast by Region (2027-2032)
        10.5.1 Egypt Market Infectious Disease Diagnostics Forecast
        10.5.2 South Africa Market Infectious Disease Diagnostics Forecast
        10.5.3 Israel Market Infectious Disease Diagnostics Forecast
        10.5.4 Turkey Market Infectious Disease Diagnostics Forecast
    10.6 Global Infectious Disease Diagnostics Forecast by Type (2027-2032)
    10.7 Global Infectious Disease Diagnostics Forecast by Application (2027-2032)
        10.7.1 GCC Countries Market Infectious Disease Diagnostics Forecast

11 Key Players Analysis
    11.1 BD
        11.1.1 BD Company Information
        11.1.2 BD Infectious Disease Diagnostics Product Offered
        11.1.3 BD Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.1.4 BD Main Business Overview
        11.1.5 BD Latest Developments
    11.2 Danaher
        11.2.1 Danaher Company Information
        11.2.2 Danaher Infectious Disease Diagnostics Product Offered
        11.2.3 Danaher Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.2.4 Danaher Main Business Overview
        11.2.5 Danaher Latest Developments
    11.3 Abbott
        11.3.1 Abbott Company Information
        11.3.2 Abbott Infectious Disease Diagnostics Product Offered
        11.3.3 Abbott Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.3.4 Abbott Main Business Overview
        11.3.5 Abbott Latest Developments
    11.4 bioMérieux
        11.4.1 bioMérieux Company Information
        11.4.2 bioMérieux Infectious Disease Diagnostics Product Offered
        11.4.3 bioMérieux Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.4.4 bioMérieux Main Business Overview
        11.4.5 bioMérieux Latest Developments
    11.5 Hologic
        11.5.1 Hologic Company Information
        11.5.2 Hologic Infectious Disease Diagnostics Product Offered
        11.5.3 Hologic Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.5.4 Hologic Main Business Overview
        11.5.5 Hologic Latest Developments
    11.6 Thermo Fisher Scientific
        11.6.1 Thermo Fisher Scientific Company Information
        11.6.2 Thermo Fisher Scientific Infectious Disease Diagnostics Product Offered
        11.6.3 Thermo Fisher Scientific Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.6.4 Thermo Fisher Scientific Main Business Overview
        11.6.5 Thermo Fisher Scientific Latest Developments
    11.7 Roche
        11.7.1 Roche Company Information
        11.7.2 Roche Infectious Disease Diagnostics Product Offered
        11.7.3 Roche Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.7.4 Roche Main Business Overview
        11.7.5 Roche Latest Developments
    11.8 DiaSorin
        11.8.1 DiaSorin Company Information
        11.8.2 DiaSorin Infectious Disease Diagnostics Product Offered
        11.8.3 DiaSorin Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.8.4 DiaSorin Main Business Overview
        11.8.5 DiaSorin Latest Developments
    11.9 QuidelOrtho
        11.9.1 QuidelOrtho Company Information
        11.9.2 QuidelOrtho Infectious Disease Diagnostics Product Offered
        11.9.3 QuidelOrtho Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.9.4 QuidelOrtho Main Business Overview
        11.9.5 QuidelOrtho Latest Developments
    11.10 Siemens Healthineers
        11.10.1 Siemens Healthineers Company Information
        11.10.2 Siemens Healthineers Infectious Disease Diagnostics Product Offered
        11.10.3 Siemens Healthineers Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.10.4 Siemens Healthineers Main Business Overview
        11.10.5 Siemens Healthineers Latest Developments
    11.11 Qiagen
        11.11.1 Qiagen Company Information
        11.11.2 Qiagen Infectious Disease Diagnostics Product Offered
        11.11.3 Qiagen Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.11.4 Qiagen Main Business Overview
        11.11.5 Qiagen Latest Developments
    11.12 Bio-Rad
        11.12.1 Bio-Rad Company Information
        11.12.2 Bio-Rad Infectious Disease Diagnostics Product Offered
        11.12.3 Bio-Rad Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.12.4 Bio-Rad Main Business Overview
        11.12.5 Bio-Rad Latest Developments
    11.13 Wondfo Biotech
        11.13.1 Wondfo Biotech Company Information
        11.13.2 Wondfo Biotech Infectious Disease Diagnostics Product Offered
        11.13.3 Wondfo Biotech Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.13.4 Wondfo Biotech Main Business Overview
        11.13.5 Wondfo Biotech Latest Developments
    11.14 Autobio
        11.14.1 Autobio Company Information
        11.14.2 Autobio Infectious Disease Diagnostics Product Offered
        11.14.3 Autobio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.14.4 Autobio Main Business Overview
        11.14.5 Autobio Latest Developments
    11.15 Daan Gene
        11.15.1 Daan Gene Company Information
        11.15.2 Daan Gene Infectious Disease Diagnostics Product Offered
        11.15.3 Daan Gene Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.15.4 Daan Gene Main Business Overview
        11.15.5 Daan Gene Latest Developments
    11.16 Innovita
        11.16.1 Innovita Company Information
        11.16.2 Innovita Infectious Disease Diagnostics Product Offered
        11.16.3 Innovita Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.16.4 Innovita Main Business Overview
        11.16.5 Innovita Latest Developments
    11.17 Hybribio
        11.17.1 Hybribio Company Information
        11.17.2 Hybribio Infectious Disease Diagnostics Product Offered
        11.17.3 Hybribio Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.17.4 Hybribio Main Business Overview
        11.17.5 Hybribio Latest Developments
    11.18 BioPerfectus
        11.18.1 BioPerfectus Company Information
        11.18.2 BioPerfectus Infectious Disease Diagnostics Product Offered
        11.18.3 BioPerfectus Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.18.4 BioPerfectus Main Business Overview
        11.18.5 BioPerfectus Latest Developments
    11.19 Sansure
        11.19.1 Sansure Company Information
        11.19.2 Sansure Infectious Disease Diagnostics Product Offered
        11.19.3 Sansure Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.19.4 Sansure Main Business Overview
        11.19.5 Sansure Latest Developments
    11.20 Liferiver
        11.20.1 Liferiver Company Information
        11.20.2 Liferiver Infectious Disease Diagnostics Product Offered
        11.20.3 Liferiver Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
        11.20.4 Liferiver Main Business Overview
        11.20.5 Liferiver Latest Developments

12 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Infectious Disease Diagnostics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
 Table 2. Infectious Disease Diagnostics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
 Table 3. Major Players of Blood Sample
 Table 4. Major Players of Respiratory Sample
 Table 5. Major Players of Urine Sample
 Table 6. Major Players of Other
 Table 7. Infectious Disease Diagnostics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
 Table 8. Global Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
 Table 9. Global Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
 Table 10. Major Players of Molecular Diagnostics
 Table 11. Major Players of Immunodiagnostics
 Table 12. Major Players of Culture & AST
 Table 13. Major Players of POCT Rapid Tests
 Table 14. Major Players of Other
 Table 15. Infectious Disease Diagnostics Market Size CAGR by Technology (2021 VS 2025 VS 2032) & ($ millions)
 Table 16. Global Infectious Disease Diagnostics Market Size by Technology (2021-2026) & ($ millions)
 Table 17. Global Infectious Disease Diagnostics Market Size Market Share by Technology (2021-2026)
 Table 18. Major Players of Respiratory Infections
 Table 19. Major Players of Hepatitis & Blood-borne
 Table 20. Major Players of Sexually Transmitted Infections
 Table 21. Major Players of Gastrointestinal Infections
 Table 22. Major Players of Other
 Table 23. Infectious Disease Diagnostics Market Size CAGR by Test Item (2021 VS 2025 VS 2032) & ($ millions)
 Table 24. Global Infectious Disease Diagnostics Market Size by Test Item (2021-2026) & ($ millions)
 Table 25. Global Infectious Disease Diagnostics Market Size Market Share by Test Item (2021-2026)
 Table 26. Infectious Disease Diagnostics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
 Table 27. Global Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
 Table 28. Global Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
 Table 29. Global Infectious Disease Diagnostics Revenue by Player (2021-2026) & ($ millions)
 Table 30. Global Infectious Disease Diagnostics Revenue Market Share by Player (2021-2026)
 Table 31. Infectious Disease Diagnostics Key Players Head office and Products Offered
 Table 32. Infectious Disease Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
 Table 33. New Products and Potential Entrants
 Table 34. Mergers & Acquisitions, Expansion
 Table 35. Global Infectious Disease Diagnostics Market Size by Region (2021-2026) & ($ millions)
 Table 36. Global Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
 Table 37. Global Infectious Disease Diagnostics Revenue by Country/Region (2021-2026) & ($ millions)
 Table 38. Global Infectious Disease Diagnostics Revenue Market Share by Country/Region (2021-2026)
 Table 39. Americas Infectious Disease Diagnostics Market Size by Country (2021-2026) & ($ millions)
 Table 40. Americas Infectious Disease Diagnostics Market Size Market Share by Country (2021-2026)
 Table 41. Americas Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
 Table 42. Americas Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
 Table 43. Americas Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
 Table 44. Americas Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
 Table 45. APAC Infectious Disease Diagnostics Market Size by Region (2021-2026) & ($ millions)
 Table 46. APAC Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
 Table 47. APAC Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
 Table 48. APAC Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
 Table 49. Europe Infectious Disease Diagnostics Market Size by Country (2021-2026) & ($ millions)
 Table 50. Europe Infectious Disease Diagnostics Market Size Market Share by Country (2021-2026)
 Table 51. Europe Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
 Table 52. Europe Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
 Table 53. Middle East & Africa Infectious Disease Diagnostics Market Size by Region (2021-2026) & ($ millions)
 Table 54. Middle East & Africa Infectious Disease Diagnostics Market Size by Type (2021-2026) & ($ millions)
 Table 55. Middle East & Africa Infectious Disease Diagnostics Market Size by Application (2021-2026) & ($ millions)
 Table 56. Key Market Drivers & Growth Opportunities of Infectious Disease Diagnostics
 Table 57. Key Market Challenges & Risks of Infectious Disease Diagnostics
 Table 58. Key Industry Trends of Infectious Disease Diagnostics
 Table 59. Global Infectious Disease Diagnostics Market Size Forecast by Region (2027-2032) & ($ millions)
 Table 60. Global Infectious Disease Diagnostics Market Size Market Share Forecast by Region (2027-2032)
 Table 61. Global Infectious Disease Diagnostics Market Size Forecast by Type (2027-2032) & ($ millions)
 Table 62. Global Infectious Disease Diagnostics Market Size Forecast by Application (2027-2032) & ($ millions)
 Table 63. BD Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 64. BD Infectious Disease Diagnostics Product Offered
 Table 65. BD Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 66. BD Main Business
 Table 67. BD Latest Developments
 Table 68. Danaher Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 69. Danaher Infectious Disease Diagnostics Product Offered
 Table 70. Danaher Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 71. Danaher Main Business
 Table 72. Danaher Latest Developments
 Table 73. Abbott Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 74. Abbott Infectious Disease Diagnostics Product Offered
 Table 75. Abbott Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 76. Abbott Main Business
 Table 77. Abbott Latest Developments
 Table 78. bioMérieux Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 79. bioMérieux Infectious Disease Diagnostics Product Offered
 Table 80. bioMérieux Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 81. bioMérieux Main Business
 Table 82. bioMérieux Latest Developments
 Table 83. Hologic Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 84. Hologic Infectious Disease Diagnostics Product Offered
 Table 85. Hologic Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 86. Hologic Main Business
 Table 87. Hologic Latest Developments
 Table 88. Thermo Fisher Scientific Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 89. Thermo Fisher Scientific Infectious Disease Diagnostics Product Offered
 Table 90. Thermo Fisher Scientific Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 91. Thermo Fisher Scientific Main Business
 Table 92. Thermo Fisher Scientific Latest Developments
 Table 93. Roche Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 94. Roche Infectious Disease Diagnostics Product Offered
 Table 95. Roche Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 96. Roche Main Business
 Table 97. Roche Latest Developments
 Table 98. DiaSorin Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 99. DiaSorin Infectious Disease Diagnostics Product Offered
 Table 100. DiaSorin Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 101. DiaSorin Main Business
 Table 102. DiaSorin Latest Developments
 Table 103. QuidelOrtho Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 104. QuidelOrtho Infectious Disease Diagnostics Product Offered
 Table 105. QuidelOrtho Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 106. QuidelOrtho Main Business
 Table 107. QuidelOrtho Latest Developments
 Table 108. Siemens Healthineers Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 109. Siemens Healthineers Infectious Disease Diagnostics Product Offered
 Table 110. Siemens Healthineers Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 111. Siemens Healthineers Main Business
 Table 112. Siemens Healthineers Latest Developments
 Table 113. Qiagen Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 114. Qiagen Infectious Disease Diagnostics Product Offered
 Table 115. Qiagen Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 116. Qiagen Main Business
 Table 117. Qiagen Latest Developments
 Table 118. Bio-Rad Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 119. Bio-Rad Infectious Disease Diagnostics Product Offered
 Table 120. Bio-Rad Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 121. Bio-Rad Main Business
 Table 122. Bio-Rad Latest Developments
 Table 123. Wondfo Biotech Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 124. Wondfo Biotech Infectious Disease Diagnostics Product Offered
 Table 125. Wondfo Biotech Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 126. Wondfo Biotech Main Business
 Table 127. Wondfo Biotech Latest Developments
 Table 128. Autobio Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 129. Autobio Infectious Disease Diagnostics Product Offered
 Table 130. Autobio Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 131. Autobio Main Business
 Table 132. Autobio Latest Developments
 Table 133. Daan Gene Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 134. Daan Gene Infectious Disease Diagnostics Product Offered
 Table 135. Daan Gene Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 136. Daan Gene Main Business
 Table 137. Daan Gene Latest Developments
 Table 138. Innovita Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 139. Innovita Infectious Disease Diagnostics Product Offered
 Table 140. Innovita Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 141. Innovita Main Business
 Table 142. Innovita Latest Developments
 Table 143. Hybribio Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 144. Hybribio Infectious Disease Diagnostics Product Offered
 Table 145. Hybribio Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 146. Hybribio Main Business
 Table 147. Hybribio Latest Developments
 Table 148. BioPerfectus Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 149. BioPerfectus Infectious Disease Diagnostics Product Offered
 Table 150. BioPerfectus Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 151. BioPerfectus Main Business
 Table 152. BioPerfectus Latest Developments
 Table 153. Sansure Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 154. Sansure Infectious Disease Diagnostics Product Offered
 Table 155. Sansure Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 156. Sansure Main Business
 Table 157. Sansure Latest Developments
 Table 158. Liferiver Details, Company Type, Infectious Disease Diagnostics Area Served and Its Competitors
 Table 159. Liferiver Infectious Disease Diagnostics Product Offered
 Table 160. Liferiver Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2021-2026)
 Table 161. Liferiver Main Business
 Table 162. Liferiver Latest Developments


List of Figures
 Figure 1. Infectious Disease Diagnostics Report Years Considered
 Figure 2. Research Objectives
 Figure 3. Research Methodology
 Figure 4. Research Process and Data Source
 Figure 5. Global Infectious Disease Diagnostics Market Size Growth Rate (2021-2032) ($ millions)
 Figure 6. Infectious Disease Diagnostics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Figure 7. Infectious Disease Diagnostics Sales Market Share by Country/Region (2025)
 Figure 8. Infectious Disease Diagnostics Sales Market Share by Country/Region (2021, 2025 & 2032)
 Figure 9. Global Infectious Disease Diagnostics Market Size Market Share by Type in 2025
 Figure 10. Global Infectious Disease Diagnostics Market Size Market Share by Technology in 2025
 Figure 11. Global Infectious Disease Diagnostics Market Size Market Share by Test Item in 2025
 Figure 12. Infectious Disease Diagnostics in Public Hospitals
 Figure 13. Global Infectious Disease Diagnostics Market: Public Hospitals (2021-2026) & ($ millions)
 Figure 14. Infectious Disease Diagnostics in Third-party Independent Laboratory
 Figure 15. Global Infectious Disease Diagnostics Market: Third-party Independent Laboratory (2021-2026) & ($ millions)
 Figure 16. Infectious Disease Diagnostics in Other
 Figure 17. Global Infectious Disease Diagnostics Market: Other (2021-2026) & ($ millions)
 Figure 18. Global Infectious Disease Diagnostics Market Size Market Share by Application in 2025
 Figure 19. Global Infectious Disease Diagnostics Revenue Market Share by Player in 2025
 Figure 20. Global Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
 Figure 21. Americas Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
 Figure 22. APAC Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
 Figure 23. Europe Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
 Figure 24. Middle East & Africa Infectious Disease Diagnostics Market Size 2021-2026 ($ millions)
 Figure 25. Americas Infectious Disease Diagnostics Value Market Share by Country in 2025
 Figure 26. United States Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 27. Canada Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 28. Mexico Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 29. Brazil Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 30. APAC Infectious Disease Diagnostics Market Size Market Share by Region in 2025
 Figure 31. APAC Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
 Figure 32. APAC Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
 Figure 33. China Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 34. Japan Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 35. South Korea Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 36. Southeast Asia Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 37. India Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 38. Australia Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 39. Europe Infectious Disease Diagnostics Market Size Market Share by Country in 2025
 Figure 40. Europe Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
 Figure 41. Europe Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
 Figure 42. Germany Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 43. France Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 44. UK Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 45. Italy Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 46. Russia Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 47. Middle East & Africa Infectious Disease Diagnostics Market Size Market Share by Region (2021-2026)
 Figure 48. Middle East & Africa Infectious Disease Diagnostics Market Size Market Share by Type (2021-2026)
 Figure 49. Middle East & Africa Infectious Disease Diagnostics Market Size Market Share by Application (2021-2026)
 Figure 50. Egypt Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 51. South Africa Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 52. Israel Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 53. Turkey Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 54. GCC Countries Infectious Disease Diagnostics Market Size Growth 2021-2026 ($ millions)
 Figure 55. Americas Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 56. APAC Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 57. Europe Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 58. Middle East & Africa Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 59. United States Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 60. Canada Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 61. Mexico Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 62. Brazil Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 63. China Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 64. Japan Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 65. Korea Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 66. Southeast Asia Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 67. India Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 68. Australia Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 69. Germany Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 70. France Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 71. UK Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 72. Italy Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 73. Russia Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 74. Egypt Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 75. South Africa Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 76. Israel Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 77. Turkey Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)
 Figure 78. Global Infectious Disease Diagnostics Market Size Market Share Forecast by Type (2027-2032)
 Figure 79. Global Infectious Disease Diagnostics Market Size Market Share Forecast by Application (2027-2032)
 Figure 80. GCC Countries Infectious Disease Diagnostics Market Size 2027-2032 ($ millions)

Companies Mentioned

Danaher

Abbott

bioMérieux

Hologic

Thermo Fisher Scientific

Roche

DiaSorin

QuidelOrtho

Siemens Healthineers

Qiagen

Bio-Rad

Wondfo Biotech

Autobio

Daan Gene

Innovita

Hybribio

BioPerfectus

Sansure

Liferiver

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff